The Business
Research Company published its Metabolic Disorders Drugs Global Market Report
2020 which provides strategists, marketers and senior management with the
critical information they need to assess the global Metabolic Disorders Drugs
market. The report provides in-depth analysis of the impact of COVID-19 on the
market, along with revised market numbers due to the effects of the
coronavirus.
The report
covers the metabolic disorders drugs market’s segments- by type: anti diabetics
drugs, anti-thyroid drugs, others (hyperparathyroidism, hypopituitarism,
hypoadrenalism), by distribution channel: hospital pharmacies, retail
pharmacies/ drug stores, others, by route of administration: oral, parenteral,
others, by drug classification: branded drugs, generic drugs, and by mode of
purchase: prescription-based drugs, over-the-counter drugs.
View Complete Report:
Metabolic Disorders Drugs Global Market Report 2020 is the
most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
The global metabolic disorders drugs market is expected to
decline from $145.9 billion in 2019 to $141.4 billion in 2020 at a compound
annual growth rate (CAGR) of -3.1%. The decline is mainly due to the COVID-19
outbreak and the measures to contain it. The pandemic is affecting industries
across the globe, including the pharmaceutical sector. The disruptions due to
extended factory closures in various countries, shortage of APIs and other
chemicals, rise in prices of key ingredients, and slowed production are the key
factors for this decline. The market is then expected to recover and grow at a
CAGR of 8% from 2021 and reach $200.8 billion in 2023.
The Food And Drug Administration (FDA) has approved various
enzyme replacement therapies for the treatment of metabolic disorders. Enzyme
replacement therapy is used for treatment of rare genetic disorders through
purified human, animal or recombinant enzymes.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Metabolic Disorders Drugs Market Characteristics
4. Metabolic Disorders Drugs Market Product Analysis
5. Metabolic Disorders Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market
21. Market Background: Pharmaceutical Drugs Market
2. Report Structure
3. Metabolic Disorders Drugs Market Characteristics
4. Metabolic Disorders Drugs Market Product Analysis
5. Metabolic Disorders Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
23. Appendix
24. Copyright And Disclaimer
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2139&type=smp
Few Points From List Of Tables
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Metabolic Disorders Drugs Market, 2019, By
Region, Value ($ Billion)
Table 4: Global Metabolic Disorders Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Historic And Forecast, By Region
………
Table 115: Global Pharmaceutical Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 116: Global Metabolic Disorders Drugs Market In 2023-
Growth Countries
Table 117: Global Metabolic Disorders Drugs Market In 2023-
Growth Segments
Table 118: Global Metabolic Disorders Drugs Market In 2023-
Growth Strategies
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
